AU723178B2 - Novel ACC synthase genes from pineapple - Google Patents
Novel ACC synthase genes from pineapple Download PDFInfo
- Publication number
- AU723178B2 AU723178B2 AU19963/97A AU1996397A AU723178B2 AU 723178 B2 AU723178 B2 AU 723178B2 AU 19963/97 A AU19963/97 A AU 19963/97A AU 1996397 A AU1996397 A AU 1996397A AU 723178 B2 AU723178 B2 AU 723178B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleotide sequence
- pineapple
- plant
- cell
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 101710194665 1-aminocyclopropane-1-carboxylate synthase Proteins 0.000 title claims description 62
- 235000007119 Ananas comosus Nutrition 0.000 title claims description 46
- 244000099147 Ananas comosus Species 0.000 title description 41
- 239000002773 nucleotide Substances 0.000 claims description 71
- 125000003729 nucleotide group Chemical group 0.000 claims description 71
- 241000196324 Embryophyta Species 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 51
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 35
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 claims description 25
- 230000009261 transgenic effect Effects 0.000 claims description 24
- 241000234671 Ananas Species 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 230000000977 initiatory effect Effects 0.000 claims description 20
- 235000013399 edible fruits Nutrition 0.000 claims description 17
- 230000000692 anti-sense effect Effects 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 10
- 240000007228 Mangifera indica Species 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 44
- 108020004414 DNA Proteins 0.000 description 43
- 239000013615 primer Substances 0.000 description 28
- 108090000623 proteins and genes Proteins 0.000 description 26
- 239000000523 sample Substances 0.000 description 23
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 238000009396 hybridization Methods 0.000 description 20
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 18
- 239000005977 Ethylene Substances 0.000 description 18
- 239000012528 membrane Substances 0.000 description 17
- 239000002299 complementary DNA Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 230000000295 complement effect Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- -1 cadmium Chemical class 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 150000007523 nucleic acids Chemical class 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical compound OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 210000002257 embryonic structure Anatomy 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 230000008121 plant development Effects 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 229930192334 Auxin Natural products 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002363 auxin Substances 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000004345 fruit ripening Effects 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 239000007997 Tricine buffer Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000005547 deoxyribonucleotide Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 3
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 229940016590 sarkosyl Drugs 0.000 description 3
- 108700004121 sarkosyl Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- 235000011178 triphosphate Nutrition 0.000 description 3
- UDPGUMQDCGORJQ-UHFFFAOYSA-N (2-chloroethyl)phosphonic acid Chemical compound OP(O)(=O)CCCl UDPGUMQDCGORJQ-UHFFFAOYSA-N 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 208000005156 Dehydration Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000005976 Ethephon Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 244000147568 Laurus nobilis Species 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- 244000141359 Malus pumila Species 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 241000713869 Moloney murine leukemia virus Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000008051 TBE buffer Substances 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 240000004922 Vigna radiata Species 0.000 description 2
- 235000006582 Vigna radiata Nutrition 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003617 indole-3-acetic acid Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000007226 seed germination Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- GHKCSRZBNZQHKW-UHFFFAOYSA-N 1-sulfanylethanol Chemical compound CC(O)S GHKCSRZBNZQHKW-UHFFFAOYSA-N 0.000 description 1
- WMPGRAUYWYBJKX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WMPGRAUYWYBJKX-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 108700005084 Multigene Family Proteins 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108020003217 Nuclear RNA Proteins 0.000 description 1
- 102000043141 Nuclear RNA Human genes 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000168036 Populus alba Species 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000589500 Thermus aquaticus Species 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 1
- 230000006578 abscission Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000020415 coconut juice Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 101150029559 hph gene Proteins 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
P/00/01i1 Regulation 3.2
AUSTRALIA
Patents Act 1990
ORIGINAL
COMPLETE SPECIFICATION STANDARD PATENT Invention Title: "NOVEL ACC SYNTHASE GENES FROM PINEAPPLE" The following statement is a full description of this invention, including the best method of performing it known to us:
TITLE
"NOVEL ACC SYNTHASE GENES FROM PINEAPPLE" FIELD OF THE INVENTION THIS INVENTION relates to ACC synthase and, in particular, novel ACC synthase genes derived from pineapple.
BACKGROUND OF THE INVENTION Ethylene is one of five well-established plant hormones. It plays an important role in virtually every phase of plant development including seed germination, fruit ripening, leaf and flower senescence, 10 and abscission. The production of ethylene may also be induced by external factors such as mechanical wounding, anaerobiosis, auxin treatment, ultraviolet light, temperature extremes, water stress, and ions such as cadmium, and lithium (Abeles, 1973, Ethylene in Plant Biology, 197-219, Academic Press, London; Yang Hoffman, 1984, 15 Annu. Rev. Plant Physiol., 35, 155-189).
The pathway for ethylene biosynthesis has been established, the first step of which involves the formation of S-adenosyl-Lmethionine (AdoMet) by S-adenosyl-L-methionine synthetase. AdoMet is subsequently converted by S-adenosyl-L-methionine methylthio- 20 adenosine-lyase (ACC synthase; EC 4.4.1.14) to the nonprotein amino acid 1-aminocyclopropane-1 carboxylic acid (ACC), the immediate precursor of ethylene in higher plants (Adams Yang, 1979, Proc. Natl.
Acad. Sci. USA, 76, 170-174). Physiological analysis has suggested that this is the key regulatory step in the pathway, (Kende, 1989, Plant Physiol., 91, Thus, the rate of endogenous expression of ACC synthase is considered to limit substantially the rate of ethylene production.
It is well known that endogenous ethylene is often deleterious to crops. In particular, increased ethylene production due to trauma caused by mechanical wounding of fruits and vegetables, and the cutting of flowers greatly diminishes their post harvest quality and storage 3 life. However, the role of ethylene in regard to initiation of flowering in plants is not so clear. In this respect, ethylene is known to inhibit flowering in most plant species but in regard to mango and species of Bromeliad including pineapple, ethylene has been shown to promote initiation of flowering (Salisbury and Ross, 1992, Plant Physiology, Wadsworth Inc., California, p. 682). Accordingly, ethylene, ethylene producing compounds and auxins have been used almost universally to artificially induce flowering in commercial pineapple production (Turnbull et al, 1993, Acta Horticulturae, 334, 83-92).
10 However, flower initiation in pineapple can occur naturally ~once a minimum plant size and age is attained (Py et al, 1987, "The a.
Cultivation of Pineapple", G.P. Maisonneuve Et Larose, Paris, p. 567; Bartholomew and Malezieux, 1994 In Schaffer and Anderson, 1994, "Handbook of Environmental Physiology of Fruit Crops, CRC Press, 15 Florida, p. 310). This generally causes problems because if natural flower .l 0. initiation occurs in a portion of the crop before the application of ethylene producing compounds thereto, crop control will only be partial.
In many countries, natural flowering of pineapple plants is a major industry problem because a substantial portion of a particular crop flowers naturally at different times in comparison to the remainder of the crop which has been induced artificially. For example, in Australia, natural initiation of flowering usually causes 5 to 40% of a summer crop to produce fruit which matures 4 to 6 weeks ahead of the normal summer harvest. This increases the number of passes required to pick that crop and generally results in some fruit being over-ripe. These factors decrease substantially the profits associated with growing a pineapple crop. Furthermore, cost benefits that would be possible if crop harvests could be planned completely cannot be achieved because a grower must artificially induce a crop at times designed to circumvent natural initiations.
Accordingly, the control of flowering to thereby control the timing and spread of fruit ripening within a crop is an important industry 4 objective. If flowering and hence the uniformity of fruit maturity within the crop can be better controlled, fewer passes will be necessary to pick the fruit, and less fruit will be lost as a consequence of over-ripeness or immaturity. Furthermore, the control of flowering and hence fruit maturity will assist substantially in the organisation of labour associated with harvesting and processing activities and allow more flexibility in planning crop schedules (Py et al, 1987, supra).
At the present time, there are no satisfactory means for the prevention of natural flowering in pineapple plants. However, a strategy 10 has been developed recently that takes advantage of the modulation properties of ACC synthase in the control of ethylene biosynthesis. In this regard, reference may be made to International Application No.
PCT/US91/06453 which is directed to inhibition of expression of endogenous ACC synthase using an antisense expression system. This 15 system comprises a DNA molecule capable of generating, when contained in a plant host cell, a complementary RNA that is sufficiently complementary to an RNA transcribed from an endogenous ACC synthase gene to prevent the synthesis of endogenous ACC synthase.
Ethylene production in fruits of transgenic tomato plants engineered using 20 this system was inhibited by 99.5% and, as a consequence, fruit ripening was suppressed. In addition, the application of ethylene or propylene to the fruits of these plants restored normal ripening.
Thus, ACC synthase genes may be used as targets for the generation of transgenic plants in which endogenous expression of ACC synthase is inhibited to effect suppression of ethylene production. The efficacy of this system, however, is predicated on the condition that the antisense RNA is sufficiently complementary to the transcript expressed from the target gene. In this regard, many studies have shown that ACC synthase is encoded by a highly divergent multigene family (for a review, see Theologis, A. 1992, Cell, 70, 181-184; Kende, 1993, Annu. Rev.
Plant Physiol. Plant Mol. Biol., 44, 283-307). Accordingly, if there is diversity between different ACC synthase genes, the use in this system for example, of a particular ACC synthase gene from one plant species would not be expected to inhibit the expression of an ACC synthase gene from another plant species. This is supported on page 5 of PCT/US91/06453 which states that "[w]hile the various ACC synthases are generally active in a variety of plant tissues, the DNAs are not completely homologous, and therefore the use of the genetic materials for control of synthesis, for example, using an antisense strategy, does not translate cross species." 10 In addition to sequence diversity of ACC synthases across species, it is well known that there is substantial sequence diversity of ACC synthases encoded within species. For example, in tomato, ACC synthase is encoded by six genes, two of which are expressed in fruit 4 ripening (Van der Straeten et al., 1990, Proc. Natl. Acad. Sci. USA, 87, 15 4859-4863; Olson et al., 1991, Proc. Natl. Acad. Sci. USA, 88, 5340-5344; Rottmann et al., 1991, J. Mol. Biol., 222, 937-961; Yipp et al., 1992, Proc.
Natl. Acad. Sci. USA, 89, 2475-2479). The other four ACC synthases have been purported to be involved in other stages of plant development.
Reference also may be made to an article by Sato and Theologis (1989, Proc. Natl. Acad. Sci. USA, 86, 6621-6625) which describes the presence of a number of homologous but different ACC synthases in zucchini. In this regard, the various ACC synthases were shown to control ethylene production during different developmental processes, thus permitting separate control of, for example, fruit ripening and seed germination.
Accordingly, if there is diversity between different ACC synthase genes within plant species, the use, for example, of a particular ACC synthase gene involved in one stage of plant development in the antisense system of PCT/US91/06453 would not be expected necessarily to inhibit the expression of an ACC synthase gene involved in another stage of plant development.
6 OBJECT OF THE INVENTION It is therefore an object of the present invention to provide new ACC synthase genes which have utility as targets for the generation of transgenic plants in which the expression of ACC synthase is substantially controlled to effect the regulation of plant development, and in particular, initiation of flowering.
It is a further object of the invention to provide a method for isolation of ACC synthase genes involved in the regulation of floral initiation of a plant.
10 SUMMARY OF THE INVENTION In one aspect of the invention, there is provided an isolated nucleotide sequence encoding a first ACC synthase enzyme of pineapple comprising the sequence of nucleotides as shown in FIG. 1.
In another aspect of the invention, there is provided an i 15 isolated nucleotide sequence encoding a second ACC synthase enzyme of pineapple comprising the sequence of nucleotides as shown in FIG. 2.
The term "nucleotide sequence" as used herein designates mRNA, RNA, cRNA, cDNA or DNA. One of skill in the art will appreciate that cDNA is complementary DNA produced from a RNA template, usually 20 by the action of RNA-dependent DNA polymerase (reverse transcriptase).
If the RNA template has not been processed to remove the introns, the cDNA will not be identical to the gene from which the RNA was transcribed.
The invention also provides homologs of the nucleotide sequences of the invention described in FIGS. 1-2. Such "homologs", as used in this specification include all nucleotide sequences encoding subsequences of the nucleotide sequences according to FIGS. 1-2.
The homologs of the invention further comprise nucleotide sequences that hybridize with any one of the nucleotide sequence of the invention under stringent conditions. Suitable hybridization conditions are discussed below.
The homologs of the invention may be prepared according to the following procedure: designing primers which are preferably degenerate which span at least a fragment of a nucleotide sequence of the invention; and (ii) using such primers to amplify, via nucleotide sequence amplification techniques, said at least a fragment from a nucleic acid extract obtained from a suitable host. Suitable nucleotide sequence amplification techniques are well known to those of skill in the art and include, for example, the Polymerase Chain Reaction (PCR), Strand 10 Displacement Amplification (SDA) and Rolling Circle Replication (RCR).
The suitable host from which a nucleic acid extract is obtained is preferably a cell or tissue obtained from a pineapple plant, preferably a D leaf of the pineapple plant, more preferably a basal white portion of the D leaf. By "obtained from" is meant that the nucleic acid extract is isolated 15 from, or derived from, a particular source of the host. For example, the nucleic acid extract may be obtained from cells or tissue isolated directly from a pineapple plant. In such a case, the cells or tissue are preferably derived from a D leaf of the pineapple plant, more preferably the basal white portion of the D leaf. Alternatively, the cells or tissue may be 20 derived from a stem apex of the pineapple plant.
Alternatively, a homolog of the invention may be obtained from a nucleotide sequence library derived from pineapple tissue. Such a library may be a pineapple cDNA library.
"Hybridization" is used here to denote the pairing of complementary nucleotide sequences to produce a DNA-DNA hybrid or a DNA-RNA hybrid. Complementary base sequences are those sequences that are related by the base-pairing rules. In DNA, A pairs with T and C pairs with G. In RNA U pairs with A and C pairs with G.
Typically, nucleotide sequences to be compared by means of hybridization are analyzed using dot blotting, slot blotting, or Southern blotting. Southern blotting is used to determine the complementarity of 8 DNA sequences. Northern blotting determines complementarity of DNA and RNA sequences or RNA and RNA sequences. Dot and Slot blotting can be used to analyze DNA/DNA, DNAIRNA or RNA/RNA complementarity. These techniques are well known by those of skill in the art. Typical procedures are described in CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (Ausubel, et al., eds.) (John Wiley Sons, Inc.
1995) at pages 2.9.1 through 2.9.20. Briefly, for Southern blotting, DNA samples are separated by size using gel electrophoresis. The sizeseparated DNA samples are transferred to and immobilized on a '10 membrane (typically, nitrocellulose) and the DNA samples are probed with *a radioactively or enzymatically or fluorochromatically labeled °complementary nucleic acid. In dot blotting and slot blotting, DNA samples are directly spotted onto a membrane (nitrocellulose or nylon).
The membrane is then probed with a labeled complementary nucleic acid.
4* 15 Typically, the following general procedure can be used to determine hybridization under stringent conditions. A nucleotide $too according to the invention (such as the nucleotide sequence of FIGS. 1 or 2 or a sub-sequence thereof) will be immobilized on a membrane using one of the above-described procedures for blotting. A sample nucleotide sequence will be labeled and used as a "probe." Using procedures well known to those skilled in the art for blotting described above, the ability of the probe to hybridize with a nucleotide sequence according to the invention can be analyzed.
A probe is a biochemical labeled with a radioactive isotope or tagged in other ways for ease in identification. A probe is used to identify a gene, a gene product or a protein. Thus a nucleotide sequence probe can be used to identify complementary nucleotide sequences. An mRNA probe will hybridize with its corresponding DNA gene.
One of skill in the art will recognize that various factors can influence the amount and detectability of the probe bound to the immobilized DNA. The specific activity of the probe must be sufficiently high to permit detection. Typically, a specific activity of at least 108 dpm/pg is necessary to avoid weak or undetectable hybridization signals when using a radioactive hybridization probe. A probe with a specific activity of 108 to 109 dpm/pg can detect approximately 0.5 pg of DNA. It is well known in the art that sufficient DNA must be immobilized on the membrane to permit detection. It is desirable to have excess immobilized DNA and spotting 10 pg of DNA is generally an acceptable amount that will permit optimum detection in most circumstances. Adding an inert polymer such as 10% dextran sulfate (mol. wt. 500,000) or PEG 10 6000 to the hybridization solution can also increase the sensitivity of the hybridization. Adding these polymers has been known to increase the ~hybridization signal. See Ausubel, supra, at p 2.10.10.
To achieve meaningful results from hybridization between a S"first nucleotide sequence immobilized on a membrane and a second 5 nucleotide sequence to be used as a hybridization probe, sufficient probe must bind to the immobilized DNA to produce a detectable signal (sensitivity) and following the washing procedure, the probe must be attached only to those immobilized sequences with the desired degree of
S
complementarity to the probe sequence (specificity).
"Stringency," as used in this specification, means the condition with regard to temperature, ionic strength and the presence of certain organic solvents, under which nucleic acid hybridizations are carried out. The higher the stringency used, the higher will be the degree of complementarity between the probe and the immobilized DNA.
"Stringent conditions" designates those conditions under which only a nucleotide sequences that have a high frequency of complementary base sequences will hybridize with each other.
Exemplary stringent conditions are 0.75 M dibasic sodium phosphate/0.5 M monobasic sodium phosphate/1 mM disodium EDTA/1% sarkosyl at about 42°C for at least about 30 minutes, 6.0 M urea/0.4% sodium laurel sulfate/0.1% SSC at about 420 C for at least about 30 minutes, 0.1 X SSC/0.1% SDS at about 68°C for at least about 20 minutes, 1 X SSC/0.1% SDS at about 55°C for about one hour, 1 X SSC/0.1% SDS at about 62 0 C for about one hour, 1 X SSC/0.1% SDS at about 68 0 C for about one hour, 0.2 X SSC/0.1% SDS at about 55°C for about one hour, 0.2 X SSC/0.1% SDS at about 62°C for about one hour, and 0.2 X SSC/0.1% SDS at about 68°C for about one hour. See, e.g. CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (Ausubel, et al., eds.) (John Wiley Sons, Inc. 1995), pages 2.10.1-2.10.16 of which are hereby incorporated by reference and 10 Sambrook, et al., MOLECULAR CLONING. A LABORATORY MANUAL (Cold Spring Harbor Press, 1989) at §§1.101-1.104.
Stringent washes are typically carried out for a total of about minutes to about 60 minutes. In certain instances, more than one stringent wash will be required to remove sequences that are not highly 15 similar to nucleotide sequences according to FIGS. 1-2 or a subsequence thereof. Typically, two washes of equal duration, such as two 15 or 30 minute washes, are used. One of skill in the art will appreciate that other longer or shorter times may be employed for stringent washes o to ensure identification of sequences similar to the nucleotide sequences 20 of FIGS. 1-2 or sub-sequences thereof.
While stringent washes are typically carried out at temperatures from about 42°C to about 680C, one of skill in the art will appreciate that other temperatures may be suitable for stringent conditions. Maximum hybridization typically occurs at about 20 to about 25°C below the Tm for DNA-DNA hybrids. It is well known in the art that Tm is the melting temperature, or temperature at which two nucleotide sequences dissociate. Methods for estimating Tm are well known in the art. See, e.g. Ausubel, supra, at page 2.10.8. Maximum hybridization typically occurs at about 10 to about 15°C below the Tm for DNA-RNA hybrids.
Other typical stringent conditions are well-known in the art.
11 One of skill in the art will recognize that various factors can be manipulated to optimize the specificity of the hybridization. Optimization of the stringency of the final washes can serve to ensure a high degree of hybridization between the nucleotide sequences according to FIGS. 1-2 or sub-sequences thereof and other similar nucleotide sequences.
In a typical hybridization procedure, DNA is first immobilized on a membrane such as a nitrocellulose membrane or a nylon membrane.
Procedures for DNA immobilization on such membranes are well known in the art. See, Ausubel, supra at pages 2.9.1-2.9.20. The membrane 10 is prehybridized at 42 0 C for 30-60 minutes in 0.75 M dibasic sodium phosphate/0.5 M monobasic sodium phosphate/1 mM disodium EDTA/1% sarkosyl. Membranes are then hybridized at 42 0 C in ACES hybridization solution (Life Technologies, Inc., Gaithersburg, Md.) containing labeled probe for one hour. Next, membranes are subjected to two high 15 stringency 10 minute washes at 42 0 C in 0.75 M dibasic sodium phosphate/0.5 M monobasic sodium phosphate/1 mM disodium EDTA/1% sarkosyl. Following this, the membranes are washed with 2 X SSC at room temperature, to remove unbound probe.
In another typical hybridization procedure, DNA immobilized 20 on a membrane is hybridized overnight at 42 0 C in prehybridization solution. Following hybridization, blots are washed with two stringent washes, such as 6.0 M urea/0.4% sodium laurel sulfate/0.1% SSC at 42'C. Following this, the membranes are washed with 2 X SSC at room temperature.
Autoradiogrpahic techniques for detecting radioactively labeled probes bound to membranes are well known in the art.
The invention further includes within its scope synonymous nucleotide sequences that encode for the ACC synthase enzymes or portions thereof shown in FIGS. 1 and 2.
In yet another aspect of the invention, there is provided a method for obtaining a DNA sequence encoding at least a portion of an ACC synthase enzyme involved in the regulation of floral initiation of a plant, said method including the steps of: inducing the production of the ACC synthase enzyme in cells or tissue of the plant; preparing RNA from said cells or tissue resulting from step reverse transcribing the RNA to produce a cDNA transcript; and isolating the DNA sequence from the cDNA transcript.
S• 10 In regard to step the production of the ACC synthase enzyme may be induced by any suitable technique. For example, the cells or tissue of the plant may be subjected to mechanical wounding, anaerobiosis, auxin treatment, ultraviolet light, temperature extremes such as for example cold shock, water stress, or ions such as cadmium, and 5 lithium. Alternatively, the cells or tissue may be treated with ethylene, propylene, acetylene or ETHEPHON. Preferably, the cells or tissue are treated with auxins such as, for example, indoleacetic acid (IAA) or sodium a-naphthalene acetate.
Suitably, the plant is a species wherein one or more of the techniques described in regard to step promotes initiation of flowering in the species. Preferably, the species is selected from mango species and species of Bromeliad such as, for example, pineapple.
The cells or tissue, from which RNA is prepared, may be derived from any suitable cells or tissue which produce an ACC synthase enzyme involved in the regulation of flowering.
In the case of pineapple, the cells or tissue are preferably derived from a D leaf of a pineapple plant, more preferably a basal white portion of the D leaf. Alternatively, the cells or tissue may be derived from a stem apex of the pineapple plant.
Preferably, the production of the ACC synthase enzyme in the cells or tissue of the plant is confirmed by suitable assay of ACC synthase activity such as for example described in an article by Lizada and Yang (1979, Anal. Biochem., 100, 140-145).
The term "RNA" as used herein refers to total RNA or poly-A' RNA.
Total RNA may be extracted in any suitable manner. For example, the plant or tissue resulting from step may be homogenised and subsequently lysed in an appropriate lysis buffer. A suitable RNA preserving compound such as guanidinium isothiocyanate may also be added to the homogenate to prevent RNase-mediated digestion of the 10 RNA. Total RNA may subsequently be isolated from the resulting homogenate by any suitable technique such as by ultracentrifugation through a CsCI 2 cushion or as described in Sambrook et al. (1989, "Molecular Cloning: A Laboratory Manual", 2nd Edition, Cold Spring Harbour, New York, Cold Spring Harbour Laboratory Press) which is 15 hereby incorporated by reference. Alternatively, total RNA may be isolated using other suitable methods such as for example those described in articles by Logemann etal. (1987, Anal. Biochem., 163, 16- Lopez-Gomez and Gomez-Lim (1992, Hortscience, 27, 440-442), Schultz et al. (1994, Plant Mol. Biol. Reporter, 12, 310-316), and Su and 20 Gibor, 1988 (Anal. Biochem., 174, 650-657) which articles are hereby incorporated by reference. Preferably, the total RNA is isolated according to a method described in Example 2.
Once total RNA has been extracted, by whichever method, poly-A' RNA may then be isolated from the total RNA, for example, by affinity chromatography on a compound containing multiple thymidine or uracil residues, to which the poly-A' tail of an messenger RNA (mRNA) can bind. Examples of suitable compounds include oligo-dT cellulose and poly-U SEPHADEX T M Poly-A' RNA can then be eluted by a suitable buffer.
Reverse transcription of the RNA resulting from step may be effected using a standard technique based on conversion of RNA to 14 first strand cDNA in the presence of a reverse transcriptase enzyme, an oligonucleotide primer complementary to the RNA and a mixture of deoxyribonucleotide triphosphates (dNTPs) such as for example dATP, dGTP, dCTP and dTTP. The cDNA transcript may comprise first strand cDNA or double stranded cDNA. In the latter case, second strand cDNA complementary to said first strand cDNA may be produced by any suitable technique. Such techniques are well known to those of skill in the art.
The oligonucleotide primer used for reverse transcription may be an oligo-dT primer or an antisense primer common to multiple 10 members of the ACC synthase family of genes. Preferably, the oligonucleotide primer is a degenerate antisense primer complementary to one or more genes of the ACC synthase gene family.
In regard to step the DNA sequence may be isolated using a suitable probe such as, for example, a nucleotide sequence 15 encoding an ACC synthase enzyme of a plant, preferably from a species of Bromeliad such as pineapple. In such a case, hybridisation techniques as for example described above may be employed in concert with the S S probe to isolate the DNA sequence. Alternatively, the DNA sequence may be isolated using a nucleotide sequence amplification technique as 20 for example referred to above. Preferably, the nucleotide sequence amplification technique is the Polymerase Chain Reaction (PCR). PCR may be carried out such as for example according to Sambrook et al.
(1989, supra; in particular, Sections 14.14-14.20) which is hereby incorporated by reference. A standard PCR mix suitably comprises a thermostable DNA polymerase, two or more oligonucleotide primers, deoxyribonucleotide triphosphates, a suitable buffer and a DNA template to be amplified.
The thermostable DNA polymerase may comprise Taq DNA polymerase which may be the native enzyme purified from Thermus aquaticus and/or a genetically engineered form of the enzyme synthesised in E. coli sold under the trade mark AMPLITAQ T M Other commercially available polymerase enzymes include Taq polymerases marketed by Promega or Pharmacia. Another thermostable DNA polymerase that could be used is Tth DNA polymerase obtainable from Thermus thermophilus. Concentration ranges of the polymerase may range from 0.5 5.0 units per 100 pL of reaction mixture.
Deoxyribonucleotide triphosphates comprising dATP, dCTP, dGTP and dTTP dNTPs) can be utilised in the assay with it being realised that dGTP may be substituted with 7-deaza-2'-deoxy GTP and 7deaza-2'-deoxy ATP can be substituted for dATP. It will also be 10 appreciated that 2'-deoxy ITP can be substituted for any dNTP. The four dNTPs may be present in a PCR reaction mixture at a concentration of 20-200 pM and at a pH of about Any suitable biological buffer may also be utilised in the Sreaction mixture such as Tris-HCI, or Tricine which can provide a pH in the range of 7.4-8.8. Tris-HCI may provide a pH of 8.3-8.8 at 20 0 C and Tricine may provide a pH of 8.4. The concentration of buffer may be mM in the case of Tris-HCI and around 300 mM in the case of Tricine.
The buffer may also comprise a source of Mg 2 such as MgCI 2 which may affect primer annealing (ii) strand dissociation i 20 temperatures of both template and PCR product, (iii) product specificity, (iv) formation of primer-dimer artifacts and enzyme activity and fidelity. Taq polymerase may require free Mg 2 on top of that bound by template DNA, primers and dNTPs. Accordingly the PCR mixture may contain 0.5 2.5 mM Mg2+ over the total dNTP concentration.
The buffer may also include KCI in a concentration of up to mM to facilitate primer annealing.
Another optional component may be 1-mercaptoethanol in a concentration of 50 mM.
Gelatin or bovine serum albumin (BSA) may also be present in a concentration range of 0.01 0.1%.
Nonionic detergents such as Tween 20, Triton X-100, or Laureth 12 in a concentration range of 0.05 to 0.1% may also be added to help stabilise the enzyme.
The primer components may be present in the PCR reaction mixture at a concentration of between 0.1 and 1.0 pM. The primer length may be between 16 40 nucleotides in length and having 45-60% G and C composition.
In the choice of primer, it is preferable to have exactly matching bases at the 3' end of the primer but this requirement decreases to being relatively insignificant at the 5' end (this is described in Nucleic 10 Acids Research 19, 3058). The preferred primers utilized in this invention are degenerate primers complementary to one or more genes of the ACC synthase gene family. More preferably, the primers are selected from the group 5'-TA(C/T)TT(C/T)GA(C/T)GG(A/C/G/T)TGGAA(A/G)GC-3', (A/G)TCCAT(A/G)TT(A/C/G/T)GC(A/G)AA(A/G)CA-3', 15 (A/C/G/T)(CIT)T(AIC/GIT)GC(AICIGIT)GA(A/G)AA-3', (A/G)CA(A/C/G/T)AC(A/C/G/T)C(G/T)(A/G)AACCA-3', (G/T)(A/G)AACCA(AIC/G/T)CC(A/C/G/T)GG(C/T)TC-3' and (A/G)GA(T/C)TA(T/C)CA(T/G)GG-3'.
It will be appreciated by those skilled in the art that nested 20 PCR may also be used to improve the sensitivity and specificity of DNA amplification wherein the DNA fragment or fragments produced subsequent to a first round of PCR with a first primer pair are used as templates for a second round of PCR using nested primers internal to the first primer pair.
In the reaction conditions applicable to PCR, an initial denaturation step may be carried out between 90-100oC, a subsequent annealing step carried out between 40-60°C and a final extension step may be carried out between 70-75 0 C. Alternatively the annealing step and extension step may be combined if considered appropriate.
The nucleotide sequences of the invention have utility as targets for the generation of transgenic variants of pineapple in which the expression of ACC synthase is substantially inhibited to effect suppression of flowering.
Accordingly, in a still further aspect of the invention, there is provided a method for generating a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said method including the steps of introducing into a pineapple plant, or plant part or cell thereof a vector comprising the nucleotide sequence of FIGS. 1 or 2 or homolog thereof wherein said nucleotide sequence is operably linked, in the sense orientation, to one or more regulatory nucleotide sequences, and growing said plant or plant part or cell thereof to generate the .".transgenic variety of pineapple.
The invention also comprises a method of generating a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said method including the steps of introducing into 5 a pineapple plant, or plant part or cell thereof a vector comprising the nucleotide sequence of FIGS. 1 or 2 or homolog thereof wherein said nucleotide sequence is operably linked, in the antisense orientation, to one or more regulatory nucleotide sequences, and growing said plant or plant part or cell thereof to generate the transgenic variety of pineapple.
s:ee** 20 A vector according to the invention may be a prokaryotic or a eukaryotic expression vector, which are well known to those of skill in the art. Such vectors may contain one or more copies of the nucleotide sequences according to the invention.
Regulatory nucleotide sequences which may be utilized to regulate expression of the nucleotide sequences of FIGS. 1 or 2 or homolog thereof, but are not limited to, a promoter, an enhancer, and a transcriptional terminator. Such regulatory sequences are well known to those of skill in the art.
Suitable promoters which may be utilized to induce expression of the nucleotide sequences of the invention include constitutive promoters and inducible promoters. A particularly preferred promoter which may be used to induce such expression is the Cauliflower Mosaic Virus (CaMV) 35S promoter.
Any suitable transcriptional terminator may be used which effects termination of transcription of a nucleotide sequence in accordance with the invention. Preferably, the nopaline synthase (NOS) terminator, as for example disclosed in United States Patent Specification No. US 5,034,322, is used as the transcription terminator.
The vector may also include a selection marker such as an antibiotic resistance gene which can be used for selection of suitable 10 transformants. Examples of such resistance genes include the nptll gene which confers resistance to the antibiotics kanamycin and G418 (Geneticin®) and the hph gene which confers resistance to the antibiotic hygromycin B.
The vector may be introduced by a number of methods 15 including transfection, projectile bombardment, electroporation or infection by Agrobacterium tumefaciens.
With reference to the above methods wherein the nucleotide sequence is expressed in the sense orientation, such methods are predicated on RNA-mediated suppression (also termed gene-silencing or 20 co-suppression) wherein transcription products of the nucleotide sequence which are substantially homologous to corresponding transcripts of an endogenous gene cause inhibition of expression of the endogenous gene. In this regard, reference may be made to WO 90/12084 (which is hereby incorporated by reference) which discloses methods for engineering transgenic plants based on RNA-mediated suppression.
With reference to the above methods wherein the nucleotide sequence is expressed in the antisense orientation, such methods are based on antisense-mediated suppression as, for example, described in WO 92/04456 (which is hereby incorporated by reference).
It will of course be appreciated that gene transplacement by homologous recombination may also be used to effect the generation of suitable transgenic plants. Such methods are well known to persons of skill in the art.
In a still further aspect, the invention contemplates a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said variety comprising the nucleotide sequence of FIGS. 1 or 2 or homolog thereof wherein said nucleotide sequence is operably linked, in the sense orientation, to one or more regulatory nucleotide sequences.
10 In yet a still further aspect of the invention, there is provided 9 a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said variety comprising the nucleotide sequence of FIGS. 1 or 2 or homolog thereof wherein said nucleotide sequence is operably linked, in the antisense orientation, to one or more regulatory 15 nucleotide sequences.
The invention further contemplates pineapple fruit produced from such transgenic plants.
BRIEF DESCRIPTION OF THE DRAWINGS In order that the invention may be readily understood and 20 put into practical effect, particular preferred embodiments will now be described by way of example with reference to the following figures in which: FIG. 1 shows the nucleotide and deduced amino acid sequences encoding a first ACC synthase enzyme of pineapple; FIG. 2 shows the nucleotide and deduced amino acid sequences encoding a second ACC synthase enzyme of pineapple; EXAMPLE 1 Treatment of Pineapple Plants with Sodium a-naphthalene acetate Twelve month old field grown Smooth Cayenne pineapple plants [Ananas comosus Merr.], Clone 10, were treated with 0.2 mL/L of 245 g/L sodium a-naphthalene acetate solution in early April (autumn, southern hemisphere). Fifty-five to sixty millilitres of solution was applied to the heart of each plant.
Samples consisting of the basal white portion of the D leaf of 5 plants were collected on the day of treatment but prior to actual treatment of the plants and every day for 10 days thereafter.
The samples were wrapped in aluminium foil, marked with an identifying number and placed in liquid nitrogen within 1 minute of removal from the plant. These samples were stored subsequently at 10 -70OC until required. Subsequent observation of the treated plants in late August confirmed successful flower induction of all treated plants.
The samples were analysed for ACC content using the method of Lizada and Yang (1979, supra). One longitudinal half of each sample was used for assay of ACC content and the other half was 15 retained for RNA extraction. Since ACC synthase has a short half-life, it would be reasonable to assume that samples having a high ACC content would also have a high level of ACC synthase activity. Thus, only .0 samples having relatively high ACC content were used for RNA extraction and subsequent amplification of DNA sequences of the ACC synthase 20 type by PCR.
EXAMPLE 2 Amplification of ACC Synthase Genes From Induced Tissue Materials and Methods: All glassware, utensils and centrifuge tubes were rinsed with water containing 0.1% diethyl pyrocarbonate (DEPC) and autoclaved in order to remove RNA degrading enzymes and protein contamination.
Solutions were incubated with DEPC final concentration) overnight and autoclaved to denature any RNases present in said solutions.
Nucleic Acid Extraction Procedure In a liquid-nitrogen-filled mortar, tissue comprising basal white portion of the D leaf (1-4 g) was ground to a fine powder. While still frozen the powder was transferred to a 100 mL beaker containing 30 mL of lysis buffer (150 mM Tris pH 7.5 with boric acid, 2% SDS, 50 mM EDTA, 1% mercaptoethanol) and stirred for 5 min at room temperature. 0.25 volume of absolute ethanol and 0.11 volume of 5 M potassium acetate were added to the homogenate and stirred for a further 3 min. One volume of chloroform isoamyl alcohol (24:1) (SEVAG) was added subsequently and mixed for an additional 3 min. The homogenate was centrifuged at 18,000 rpm for 10 min in a prechilled centrifuge. The 10 recovered aqueous phase was extracted twice with phenol-chloroform or until no interphase (proteins and carbohydrates) was apparent.
After careful removal of the aqueous phase, nucleic acids were precipitated by the addition of 2.25 volumes of absolute ethanol.
After incubation for 2 hrs at -20°C, nucleic acids were centrifuged for 15 min at 18,000 rpm, dried and redissolved in 10 mL of DEPC treated 8 M LiCI was added to a final concentration of 3 M and the mixture incubated overnight at -20 0 C. RNA was collected by centrifugation (18,000 rpm, for 30 min at 4 oC) and washed twice in 80% ethanol at room temperature and dried. The RNA pellet was resuspended subsequently in 20 300 pL of DEPC treated water, and RNA precipitated by adding sodium acetate to a final concentration of 0.3 M and 2.5 volumes of absolute ethanol. After overnight incubation at -70 0 C, the RNA was pelleted by centrifugation for 30 min at 14,000 rpm (4 The pellet was washed twice in 80% ethanol and vacuum dried for 10 min. The RNA was then resuspended in 50 pL of DEPC treated sterile water, quantified spectrophotometrically and stored at -70 0
C.
Genomic DNA was pelleted from the supernatant collected after the LiCI precipitation step by the addition of 2 volumes of absolute ethanol, kept at -20oC for 2 hrs and centrifuged at 12,000 rpm for 30 min.
The DNA pellet was resuspended in 500 pL of TE buffer, quantified spectrophotometrically and stored at -20 0
C.
Formaldehyde Denaturing Gel Electrophoresis of RNA Ten pg of total RNA was electrophoresed on a 1% agarose gel at 80 V for 1 hr. The gel was prepared by adding 0.5 g of agarose, mL of 10x MOPS, 36 mL of DEPC treated water and 9 mL of formaldehyde. RNA samples were prepared by adding 25 pL of RNA loading buffer (containing ethidium bromide) to 5 pL of RNA and denatured at 70°C for 5 min, followed by chilling on ice for 2 min.
Electrophoresis was conducted in Ix MOPS buffer. The gel was photographed immediately after electrophoresis.
S: 10 DNA Gel Electrophoresis The integrity of genomic DNA was checked by electrophoresis on a 0.8% agarose gel (prepared in 1X TBE buffer) at volts for 1 hr. 10X loading buffer was added to approximately 4 pg of DNA and electrophoresis conducted in 1X TBE buffer. The gel was 15 stained in an ethidium bromide solution (66 pg/mL) and photographed as described above.
Design of Primers for Amplification of ACC Synthases From Higher Plants Homology studies of several ACC synthase proteins revealed various conserved regions among this family of proteins. Those regions were used in designing degenerate oligonucleotides by reverse translating the amino acid sequence and taking in account the degeneracy of the genetic code. As a result, several degenerate oligonucleotides were synthesized and are shown in Table 1.
Amplification of acacc2 Reverse transcription of RNA was performed using 1 pg total RNA and 2.5 U of Moloney Murine Leukemia Virus (MMLV) reverse transcriptase in a reaction mixture of 10 mM Tris-HCI, pH 8.3 containing mM KCI, 5 mM MgCI 2 1 mM of each dNTP, 1 U RNase inhibitor and 2.5 pM of oligo-dT primer. The reaction mixture was incubated for 30 min at 42°C and then heated to 99°C for 5 min to inactivate the reverse transcriptase. The DNA resulting from this procedure was amplified using U AMPLITAQ DNA Polymerase in a reaction mixture of 10 mM Tris- HCI, pH 8.3 containing 2 mM MgCI 2 50 mM KCI, and 0.15 pM of EZ-5 and EZ-7 (Table After an initial 3 min period of denaturation at 94°C, the PCR parameters were 1 min template denaturation at 94 0 C, 1 min primer annealing at 48°C and 2 min primer extension at 72°C for 45 cycles. A final extension step of 15 min at 72°C was used subsequently to ensure full length amplification products.
The products of this PCR reaction were further amplified using a second set of oligonucleotide primers EZ-7 and EZ-8 (Table 1).
SThe reaction consisted of adding to a tube a sample of the products .obtained from the previous amplification and 2.5 U AMPLITAQ DNA Polymerase in a reaction mixture of 10 mM Tris-HCI, pH 8.3 containing mM MgCI 2 50 mM KCI, 0.2 mM of each dNTP, 0.1% gelatin and 0.15 pM of each primer in a total volume of 100 pL. The PCR parameters were 30 sec template denaturation at 94°C, 30 sec primer annealing at 480C and 1.5 min primer extension at 72°C for 30 cycles. The PCR ~products were analysed on 0.8% agarose gels and visualized with ethidium bromide.
Subcloning and Sequencing of PCR Products The DNA amplified by PCR was ligated into pBluescript (SK (Stratagene, La Jolla, CA). The ligation mixtures were used to transform E. coli DH5a. Transformants were selected on LB plates containing ampicillin (50 mg/mL) and X-gal (0.033% Plasmid DNA was isolated using the alkaline lysis method.
DNA sequencing was carried out using Applied Biosystems
PRISM
T M Ready Reaction DyeDeoxy T M Terminator Cycle Sequencing kit.
Results: Agarose gel electrophoresis of the amplification products revealed the presence of a DNA band having a mobility corresponding with that of a 0.95 Kb DNA fragment. The DNA fragments corresponding 24 to this band were subcloned into pBluescript and analysis of several recombinant plasmids revealed the presence of two different inserts of approximately the same length but with different restriction patterns. The two different clones were named acacc2 and acacc3 respectively.
The nucleotide sequence of acacc2 and the deduced amino acid sequence thereof are shown in FIG. 1. Comparison of these sequences with other published ACC synthase sequences indicates that acacc2 is a cDNA coding for a member of the ACC synthase family in pineapple. Searches in all the available protein and DNA data banks 10 failed to find 100% homology with any existing clone. The highest homology found at the DNA level using the BLASTN program was 69% respectively with a Vigna radiata gene Z12135 (EMBL data bank) and a S. tuberosum gene Z27235 (EMBL data bank). Similarly, at the protein level, the highest homology found using the program BLASTX was 78% 15 with a Vigna radiata ACC synthase, entry PN0477 (PIR database).
The nucleotide sequence of acacc3 and the deduced amino acid sequence thereof are shown in FIG. 2. Nucleotide sequence analysis of acacc3 suggests that this DNA product was amplified either from small residual amounts of genomic DNA present in the RNA preparation or from heterologous nuclear RNA which had not been processed into mRNA.
Comparison of the nucleotide and deduced amino acid sequences of acacc3 with other published ACC synthase sequences indicates that acacc3 encodes a member of the ACC synthase family in pineapple. The highest homology found at the DNA level was 67% respectively with a Malus sylvestris mRNA clone U083294 (GenBank database) and a Malus domestica mRNA clone L31347 (GenBank database). At the protein level, the highest homology found was 75% with an ACC synthase from a Musa species, e233391 (GenBank database).
Analysis of the above DNA sequences reveals that sizes of acacc2 and acacc3 are 968 bp and 961 bp respectively. Each of these DNA sequences represents approximately 75% of the coding region relating thereto.
EXAMPLE 3 Stable Integration and Expression of ACC Synthase Antisense Genes in Pineapple (Ananas comosus Merrill.) Materials and Methods Initiation of somatic embryogenesis Meristems are excised from the crown of a pineapple fruit 10 and placed on MS media (Murashige and Skoog, 1962, Physiologia Plantarum, 15:473-497) containing 2.5 mg/L 6-benzylamino purine (BAP).
When subcultured at a two-weekly interval, buds/shoots start to proliferate after 3 to 5 months. Leaf base tissue or stem tissue is then excised and placed on callus media (Wakasa, 1989, In "Biotechnology in 15 Agriculture and Forestry 5 Trees 11", Ed Bajaj, Y. P. S. Springer-Verlag, London) containing MS, 10 mg/L BAP and 10 mg/L sodium anaphthalene acetate (NAA). In the case of leaf base material, callus forms in 24 to 34 days on over 60% of explants. In the case of stem tissue, callus will form on over 90% of explants in 13 to 24 days. Leaf explants are preferred as they produce callus of a higher quality with a greater proliferation rate.
Transformation vector A transformation vector which may be utilised for generating a transgenic variety of pineapple, wherein expression of an ACC synthase enzyme is substantially inhibited, may be constructed by operably linking the nucleotide sequence of FIG. 1 or FIG. 2, in the antisense orientation, to a suitable promoter. The vector may also contain a selectable marker such as the kanamycin or hygromycin resistance gene. Plasmid DNA for microprojectile bombardment can be purified using the commercially available QIAGEN kit.
Bombardment conditions Calli (embryos) are bombarded using a particle inflow gun (Finer, Vain, Jones, and McMullen, 1992, Plant Cell Reports, 11:323-328).
Gold particles of 1-1.6 pm diameter (BioRad Laboratories, Hercules, Ca, USA) are used as microprojectiles wherein a quantity of particles is washed with 100% ethanol and three times with sterile water before resuspension in sterile water. For coating of microprojectiles, 50 pL of the gold suspension is mixed with 1.0 pg/pL plasmid DNA, 50 pL 2.5 M CaCI, and 20 uL 0.5 M spermidine free base. All solutions are kept at room temperature.
10 The suspension is vortexed for 5 minutes then allowed to settle for 1 minute then centrifuged for 10 secs at 13,000 G before 100 pL of the supernatant is removed and discarded. The remaining suspension is vortexed immediately before utilising 5 pL of the mixture for each bombardment.
15 Calli (embryos) are arranged, without overlap, in an area of approximately 20 mm diameter in the centre of a petri-dish. A protective baffle of stainless steel mesh with an aperture of 210 pm (Franks and Birch, 199 1, Aust. J. Plant Physiol. 18, 471-480) is placed over the tissue during bombardment. The pressure of the helium blast is 800 to 1000 kPa and the distance to the target embryos from the filter unit containing the gold coated particles is 15 to 20 cm.
Selection and regeneration of transformed plantlets Following bombardment, calli (embryos) are allowed to recover over several days on callus media, prior to selection on callus media containing kanamycin monosulfate (200 pg/mL) or hygromycin pg/mL). Calli (embryos) are then selected for kanamycin or hygromycin resistance after several weeks on such media.
For germination, calli (embryos) are subsequently transferred to a shoot regeneration media (Mathews and Rangan, 1981, Scientia Horticulturae 14 227-234) containing MS, 5% coconut water and 400 mg/L casein hydrolysate. Within 1 to 2 months the callus will initiate shoots. Single plantlets are then transferred onto a rooting media (Wakasa, 1989, In "Biotechnology in Agriculture and Forestry 5 Trees II", Ed Bajaj, Y. P. S. Springer-Verlag, London.) containing MS and 1 mg/L NAA. Rooting will occur within 2 weeks and the plantlets are then transferred to MS media without hormones for further growth.
Initiation of flowering in such plants may be induced artificially, for example, by exogenous application of ETHEPHON, ethylene or propylene thereto.
The use of such methods, in concert with the nucleotide sequences, homologs or sub-sequences of the invention, enable the generation of transgenic pineapple varieties in which natural flowering is inhibited substantially. It is anticipated that such transgenic varieties will provide for substantial advantage because they could be induced to flower in a narrow spectrum of time which would thereby decrease the 15 spread of fruit maturity within a crop. Accordingly, fewer passes would be necessary to pick the fruit, and less fruit would be lost as a consequence of over-ripeness or immaturity. Furthermore, the control of flowering in such transgenic pineapple varieties will assist substantially in the organisation of labour associated with harvesting and processing activities thereof and would be of great value where pineapple is harvested mechanically.
TABLE I Degenerate oligonucleotidles designed to amplify ACC synthase genes and cDNAs from higher plants.
EZ-2 15' TA(C/T)TT(C/T)GA(C/T)GG(A/C/G/T)TGGAA(A/G)GC 3' EZ-4 5' TC(A/G)TCCAT(A/G)TT(A/C/G/T)GC(A/G)AACA/G)CA 3' 5' CA ATGGG T(A/C/G/T) GC GA AA 3' EZ-6 5' GC AA CA AC C(G/T) AACCA 3' EZ-7 5' AC(A/C/G/T)C(G/T) (A/G)AACCA(A/C/G/T)CC(A/C/G/T)GG(C/T)TC 3' Erz-8 15' TT(T/C)CA(A/G)GA(T/C)TA(T/C)CA(T/G)GG 3' a a
Claims (18)
1. An isolated nucleotide sequence which encodes an ACC synthase enzyme of pineapple comprising an amino acid sequence shown in FIG. 1.
2. The isolated nucleotide sequence of Claim 1, wherein the nucleotide sequence has a sequence of nucleotides as shown in FIG. 1.
3. An isolated nucleotide sequence which encodes an ACC synthase enzyme of pineapple comprising an amino acid sequence shown in FIG. 2.
4. The isolated nucleotide sequence of Claim 3, wherein the nucleotide sequence has a sequence of nucleotides as shown in FIG. 2. An isolated nucleotide sequence which hybridizes under high stringency wash conditions with a sequence of nucleotides set forth in FIG. 1 or FIG. 2, said high stringency wash conditions selected from the group consisting of: 0.1 x SSC/0.1% SDS at about 68°C for at least about 20 minutes; (ii) 0.2 x SSC/0.1% SDS at about 68°C for about one S: hour; 20 (iii) 0.2 x SSC/0.1% SDS at about 55 0 C for about one hour; and (iv) 0.2 x SSC/0.1% SDS at about 62 0 C for about one hour.
6. An isolated nucleotide sequence as claimed in Claim wherein said high stringency wash conditions are selected from the group consisting of: 0.1 x SSC/0.1% SDS at about 68°C for at least about minutes; and (ii) 0.2 x SSC/0.1% SDS at about 68 0 C for about one hour.
7. An isolated nucleotide sequence as claimed in Claim 5 or Claim 6, wherein said nucleotide sequence encodes an ACC synthase.
8. An isolated nucleotide sequence as claimed in any one of Claim 3-7, wherein said nucleotide sequence is obtained from a plant cell or tissue.
9. An isolated nucleotide sequence as claimed in Claim 8 wherein said plant cell or tissue is obtained from a mango plant or a species of Bromeliad. An isolated nucleotide sequence as claimed in Claim 9 wherein said plant cell or tissue is obtained from a pineapple plant.
11. An isolated nucleotide sequence as claimed in Claim wherein said plant cell or tissue is obtained from a D leaf of the pineapple plant.
12. An isolated nucleotide sequence as claimed in Claim 11 wherein said plant cell or tissue is obtained from a basal white portion of "the D leaf.
13. An isolated nucleotide sequence as claimed in Claim wherein said plant cell or tissue is obtained from a stem apex of the a.. pineapple plant.
14. A method of generating a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said method "including the steps of introducing into a pineapple plant, or plant part or cell thereof a vector comprising a nucleotide sequence according to any one of Claims 1-13 wherein said nucleotide sequence is operably linked, in the sense orientation, to one or more regulatory nucleotide sequences, and growing said plant or plant part or cell thereof to generate the transgenic variety of pineapple. A method of generating a transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said method including the steps of introducing into a pineapple plant, or plant part or cell thereof a vector comprising a nucleotide sequence according to any one of Claims 1-13 wherein said nucleotide sequence is operably linked, in the antisense orientation, to one or more regulatory nucleotide sequences, and growing said plant or plant part or cell thereof to generate the transgenic variety of pineapple.
16. A vector which contains at least one copy of a nucleotide sequence as claimed in any one of Claims 1-13.
17. A vector as claimed in Claim 16 wherein said nucleotide sequence is under control of one or more regulatory sequences.
18. A transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said variety comprising a nucleotide sequence according to any one of Claims 1-13 wherein said nucleotide sequence is operably linked, in the sense orientation, to one or more regulatory nucleotide sequences.
19. A transgenic variety of pineapple in which natural initiation of flowering is substantially inhibited, said variety comprising a nucleotide sequence according to any one of Claims 1-13 wherein said nucleotide sequence is operably linked, in the antisense orientation, to one or more leO :regulatory nucleotide sequences.
20. A pineapple fruit, fruit part or cell thereof produced from a 20 transgenic variety of pineapple according to Claims 18 or 19.
21. A nucleotide sequence substantially as described herein with ."reference to the accompanying drawings. t .DATED this Nineteenth day of June 2000 THE UNIVERSITY OF QUEENSLAND, GOLDEN CIRCLE LIMITED AND THE STATE OF QUEENSLAND By their Patent Attorneys FISHER ADAMS KELLY
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU19963/97A AU723178B2 (en) | 1996-05-01 | 1997-05-01 | Novel ACC synthase genes from pineapple |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN9582 | 1996-05-01 | ||
| AUPN9582A AUPN958296A0 (en) | 1996-05-01 | 1996-05-01 | Novel acc synthase genes from pineapple |
| AU19963/97A AU723178B2 (en) | 1996-05-01 | 1997-05-01 | Novel ACC synthase genes from pineapple |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1996397A AU1996397A (en) | 1997-11-06 |
| AU723178B2 true AU723178B2 (en) | 2000-08-17 |
Family
ID=25617675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU19963/97A Ceased AU723178B2 (en) | 1996-05-01 | 1997-05-01 | Novel ACC synthase genes from pineapple |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU723178B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115786290A (en) * | 2022-11-30 | 2023-03-14 | 郑州尼采生物科技有限公司 | Method for converting S adenosylmethionine into ACC (ACC) by using magnetic nano immobilized enzyme |
-
1997
- 1997-05-01 AU AU19963/97A patent/AU723178B2/en not_active Ceased
Non-Patent Citations (3)
| Title |
|---|
| LUIS JC ET AL (1995) MOL. GEN. GENET. 246: 496-508 * |
| NAKAGAWA N ET AL (1991) PLANT CELL PHYSIOL. 32(8): 1153-1163 * |
| OLSON DC ET AL (1995) J. BIOL. CHEM. 270(23): 14056-14061 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1996397A (en) | 1997-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6194639B1 (en) | ACC synthase genes from pineapple | |
| EP1200612B1 (en) | Dna encoding a plant deoxyhypusine synthase, transgenic plants and a method for controlling senescence and programmed cell death in plants | |
| JPH11501819A (en) | Transgenic plants with altered aging characteristics | |
| US6184449B1 (en) | 1-Aminocyclopropane-1-carboxylate synthase genes from rosa to control ethylene levels in roses | |
| US6864406B1 (en) | ACC synthase gene | |
| Torki et al. | Differential expression of a polygalacturonase gene family in Arabidopsis thaliana | |
| US5874269A (en) | Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plant | |
| AU697450B2 (en) | Processes for inhibiting and for inducing flower formation in plants | |
| AU723178B2 (en) | Novel ACC synthase genes from pineapple | |
| CA2304103C (en) | Control of plant abscission and pod dehiscence or shatter | |
| Hrazdina et al. | Down regulation of ethylene production in'Royal Gala'apples | |
| EP1339858B1 (en) | Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants | |
| US6723839B1 (en) | Partial gene sequence from pelargonium to control ethylene levels in geraniums | |
| CA2401991A1 (en) | Melon promoters for expression of transgenes in plants | |
| Gonzalez et al. | Characterisation of three ACC synthase gene family members during post-harvest-induced senescence in broccoli (Brassica oleracea L. var. italica) | |
| US6448474B1 (en) | Purified proteins, recombinant DNA sequences and processes for controlling the ripening of coffee plants | |
| AU721557B2 (en) | Polyphenol oxidase genes from lettuce and banana | |
| Zhou et al. | Identification of genes associated with BA-induced apple fruitlet abscission | |
| US6831168B1 (en) | Aldehyde oxidase gene derived from plant and utilization thereof | |
| JP3030015B2 (en) | Ethylene low sensitivity plant | |
| Botella et al. | Plant Genetic Engineering Laboratory, Department of Botany, University of Queensland, Brisbane Qld 4072, Australia | |
| Olivier | Differential gene expression during berry ripening in Vitis vinifera (cv Chardonnay): isolation of specific sequences through subtractive cloning | |
| Shi et al. | A pear 1-aminocyclopropane-1-carboxylate synthase gene preferentially expressed in leaves | |
| MURRAY | CHARACTERISATION OF ACC SYNTHASE DURING LEAF DEVELOPlVIENT IN WHITE CLOVER (Trifolium repens L.) | |
| ORCHID | CLONING AND CHARACTERIZATION OF 1-AMINOCYCLOPROPANE-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| GM | Mortgages registered |
Name of requester: NATIONAL AUSTRALIA BANK |